These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 18630678
21. Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Hui L, Zheng Y, Yan Y, Bargonetti J, Foster DA. Oncogene; 2006 Nov 23; 25(55):7305-10. PubMed ID: 16785993 [Abstract] [Full Text] [Related]
22. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives. Onuoha SC, Mukund SR, Coulstock ET, Sengerovà B, Shaw J, McLaughlin SH, Jackson SE. J Mol Biol; 2007 Sep 14; 372(2):287-97. PubMed ID: 17662999 [Abstract] [Full Text] [Related]
23. Hsp90 inhibitor geldanamycin increases the sensitivity of resistant ovarian adenocarcinoma cell line A2780cis to cisplatin. Solár P, Horváth V, Kleban J, Koval' J, Solárová Z, Kozubík A, Fedorocko P. Neoplasma; 2007 Sep 14; 54(2):127-30. PubMed ID: 17319785 [Abstract] [Full Text] [Related]
24. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells. Kurashina R, Ohyashiki JH, Kobayashi C, Hamamura R, Zhang Y, Hirano T, Ohyashiki K. Cancer Lett; 2009 Oct 18; 284(1):62-70. PubMed ID: 19464103 [Abstract] [Full Text] [Related]
25. The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide. Lee WY, Chen YC, Shih CM, Lin CM, Cheng CH, Chen KC, Lin CW. Toxicol Appl Pharmacol; 2014 Jan 01; 274(1):55-62. PubMed ID: 24211270 [Abstract] [Full Text] [Related]
26. Inhibition of hsp90 compromises the DNA damage response to radiation. Dote H, Burgan WE, Camphausen K, Tofilon PJ. Cancer Res; 2006 Sep 15; 66(18):9211-20. PubMed ID: 16982765 [Abstract] [Full Text] [Related]
27. Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Choi EJ, Kim GH. Phytomedicine; 2008 Sep 15; 15(9):683-90. PubMed ID: 18541420 [Abstract] [Full Text] [Related]
28. [In vitro study of expression and effects of HSP70/HSP90 in nasopharyngeal carcinoma cells after thermotherapy]. Cui XB, Liu W, Li LX, Wang W, Zheng YQ, Guo LL. Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul 15; 40(4):628-31. PubMed ID: 19764559 [Abstract] [Full Text] [Related]
29. Indirect participation of Hsp90 in the regulation of the cyclin E turnover. Bedin M, Catelli MG, Cabanié L, Gaben AM, Mester J. Biochem Pharmacol; 2009 Jan 15; 77(2):151-8. PubMed ID: 18977205 [Abstract] [Full Text] [Related]
30. The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivo. Newcomb EW, Lukyanov Y, Schnee T, Esencay M, Fischer I, Hong D, Shao Y, Zagzag D. Anticancer Drugs; 2007 Sep 15; 18(8):875-82. PubMed ID: 17667592 [Abstract] [Full Text] [Related]
31. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells. Choi EJ, Bae SM, Ahn WS. Arch Pharm Res; 2008 Oct 15; 31(10):1281-5. PubMed ID: 18958418 [Abstract] [Full Text] [Related]
32. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells. Zhang YG, Du Q, Fang WG, Jin ML, Tian XX. Int J Oncol; 2008 Sep 15; 33(3):595-602. PubMed ID: 18695891 [Abstract] [Full Text] [Related]
33. Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells. Choi SH, Im E, Kang HK, Lee JH, Kwak HS, Bae YT, Park HJ, Kim ND. Cancer Lett; 2005 Sep 28; 227(2):153-62. PubMed ID: 16112418 [Abstract] [Full Text] [Related]
34. The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association. Nagata Y, Anan T, Yoshida T, Mizukami T, Taya Y, Fujiwara T, Kato H, Saya H, Nakao M. Oncogene; 1999 Oct 28; 18(44):6037-49. PubMed ID: 10557093 [Abstract] [Full Text] [Related]
35. Potent cytotoxic C-11 modified geldanamycin analogues. Tian ZQ, Wang Z, MacMillan KS, Zhou Y, Carreras CW, Mueller T, Myles DC, Liu Y. J Med Chem; 2009 May 28; 52(10):3265-73. PubMed ID: 19405528 [Abstract] [Full Text] [Related]
36. Immune expression and inhibition of heat shock protein 90 in uveal melanoma. Faingold D, Marshall JC, Antecka E, Di Cesare S, Odashiro AN, Bakalian S, Fernandes BF, Burnier MN. Clin Cancer Res; 2008 Feb 01; 14(3):847-55. PubMed ID: 18245548 [Abstract] [Full Text] [Related]
37. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells. Moh MC, Zhang T, Lee LH, Shen S. Carcinogenesis; 2008 Dec 01; 29(12):2298-305. PubMed ID: 18845560 [Abstract] [Full Text] [Related]
38. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells. Zhang Z, Li HM, Zhou C, Li Q, Ma L, Zhang Z, Sun Y, Wang L, Zhang X, Zhu B, Hong YS, Wu CZ, Liu H. J Exp Clin Cancer Res; 2016 Sep 22; 35(1):149. PubMed ID: 27658586 [Abstract] [Full Text] [Related]
39. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate. Chintalapati M, Truax R, Stout R, Portier R, Losso JN. J Agric Food Chem; 2009 Jun 24; 57(12):5201-10. PubMed ID: 19476359 [Abstract] [Full Text] [Related]
40. Lack of telopeptides in fibrillar collagen I promotes the invasion of a metastatic breast tumor cell line. Demou ZN, Awad M, McKee T, Perentes JY, Wang X, Munn LL, Jain RK, Boucher Y. Cancer Res; 2005 Jul 01; 65(13):5674-82. PubMed ID: 15994941 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]